GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 817 filers reported holding GLAXOSMITHKLINE PLC in Q3 2020. The put-call ratio across all filers is 0.91 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $7,781,000 | +6.3% | 178,740 | +6.4% | 0.01% | +20.0% |
| Q1 2022 | $7,317,000 | +56.6% | 167,964 | +58.6% | 0.01% | +66.7% |
| Q4 2021 | $4,671,000 | +22.1% | 105,929 | +5.8% | 0.00% | 0.0% |
| Q3 2021 | $3,826,000 | +22.3% | 100,119 | +27.4% | 0.00% | +50.0% |
| Q2 2021 | $3,129,000 | +90.6% | 78,586 | +70.8% | 0.00% | +100.0% |
| Q1 2021 | $1,642,000 | +12.3% | 46,018 | +15.8% | 0.00% | 0.0% |
| Q4 2020 | $1,462,000 | -98.6% | 39,739 | -98.6% | 0.00% | -98.9% |
| Q3 2020 | $107,032,000 | +22.3% | 2,843,567 | +32.5% | 0.10% | +14.5% |
| Q2 2020 | $87,516,000 | +3092.8% | 2,145,517 | +2865.6% | 0.08% | +2666.7% |
| Q1 2020 | $2,741,000 | +293.3% | 72,347 | +387.9% | 0.00% | +200.0% |
| Q4 2019 | $697,000 | – | 14,828 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 100,000 | $3,680,000 | 12.40% |
| Black Creek Investment Management Inc. | 7,443,061 | $273,905,000 | 8.54% |
| KAHN BROTHERS GROUP INC | 1,281,924 | $47,174,803,000 | 8.23% |
| Camber Capital Management LP | 3,500,000 | $128,800,000 | 4.52% |
| Eversept Partners, LP | 946,581 | $35,196,522 | 4.13% |
| EQUITY INVESTMENT CORP | 2,321,164 | $85,419,000 | 3.98% |
| Galibier Capital Management Ltd. | 575,741 | $21,187,000 | 3.66% |
| Keystone Financial Planning, Inc. | 217,399 | $8,000,000 | 3.32% |
| CLIFFORD CAPITAL PARTNERS LLC | 217,817 | $8,016,000 | 3.14% |
| CLARK ESTATES INC/NY | 485,000 | $17,848,000 | 2.52% |